Zobrazeno 1 - 10
of 49
pro vyhledávání: '"J A, Gebhart"'
Autor:
Mitch Dowsett, Martine J. Piccart-Gebhart, Brian Leyland-Jones, Dimitrios Zardavas, Phuong Dinh, Richard D. Gelber, Kathleen I. Prichard, Nadia Harbeck, Masakazu Toi, Giuseppe Viale, Federico Rojo, Denis Larsimont, Evandro de Azambuja, Astrid Kiermaier, Margaret Hills, Varvara Polydoropoulou, Michael Gnant, Urania Dafni, Martin Filipits
Table S1: Summary of baseline characteristics for the current analysis cohort vs. the Remainder of HERA patients Table S2: Summary of Disease-free Survival by subgroup of patients Table S3: Summary of Overall Survival by subgroup of patients Table S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7444b3192f76c71c3908c1c5cead8b75
https://doi.org/10.1158/1078-0432.22469921.v1
https://doi.org/10.1158/1078-0432.22469921.v1
Autor:
Carmine De Angelis, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Lieveke Ameye, Marianne Paesmans, Sarra El-Abed, Anup Choudhury, Sylvia Napoleone, Saranya Chumsri, Martine J. Piccart-Gebhart, Alvaro Moreno-Aspitia, Henry Leonidas Gomez, Giuseppe Viale, Susan G. Hilsenbeck, Mothaffar F. Rimawi, C. Kent Osborne, Evandro de Azambuja, Rachel Schiff
Publikováno v:
Journal of Clinical Oncology. 40:522-522
522 Background: Our preclinical findings suggest a role for the mevalonate pathway (MVA) in treatment resistance in HER2+ BC by providing alternative growth and survival signaling to bypass potent HER2 blockade, which could be overcome by the MVA inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b53c03ec63c22920f440593f84007df
https://doi.org/10.1200/jco.2022.40.16_suppl.522
https://doi.org/10.1200/jco.2022.40.16_suppl.522
Autor:
Diogo Martins-Branco, Angela Loizidou, Guilherme Nader Marta, Ana Tecic Vuger, Veronique Debien, Lieveke Ameye, Mariana Brandão, Kevin Punie, Chloe Spilleboudt, Karen Willard-Gallo, Ahmad Awada, Martine J. Piccart-Gebhart, Evandro de Azambuja
Publikováno v:
Journal of Clinical Oncology. 40:1543-1543
1543 Background: Patients (pts) with cancer have increased mortality from COVID-19 and their vaccination is crucial to prevent severe infection. We aimed to identify demographic and laboratory determinants of humoral immune responses to COVID-19 vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2168cad7ad4e5ad5268b6b2c4f72e45e
https://doi.org/10.1200/jco.2022.40.16_suppl.1543
https://doi.org/10.1200/jco.2022.40.16_suppl.1543
Autor:
Aditya Bardia, Sara M. Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Hope S. Rugo, Adam Brufsky, Kevin Kalinsky, Javier Cortes, Joyce O'Shaughnessy, Veronique C Dieras, Lisa A. Carey, Luca Gianni, Martine J. Piccart-Gebhart, Sibylle Loibl, Yanni Zhu, See-Chun Phan, Sara A. Hurvitz
Publikováno v:
Journal of Clinical Oncology. 40:1071-1071
1071 Background: Treatment goals for pts with metastatic breast cancer include extended survival and improved quality of life (QoL). SG is an antibody-drug conjugate composed of an anti–Trop-2 antibody coupled to the cytotoxic SN-38 payload via a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::677a81b2dea812d5a023b1ea38460e45
https://doi.org/10.1200/jco.2022.40.16_suppl.1071
https://doi.org/10.1200/jco.2022.40.16_suppl.1071
Autor:
Guilherme Nader Marta, Chloe Spilleboudt, Diogo Martins-Branco, Ana Tecic Vuger, Veronique Debien, Lieveke Ameye, Mariana Brandão, Kevin Punie, Angela Loizidou, Karen Willard-Gallo, Ahmad Awada, Martine J. Piccart-Gebhart, Evandro de Azambuja
Publikováno v:
Journal of Clinical Oncology. 40:1537-1537
1537 Background: Patients (pts) with cancer are at increased risk of severe COVID-19. Both underlying malignancy and anti-cancer treatments influence the immune system, potentially impacting the level of vaccine protection achieved. Methods: A system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1330d3383e422ff158a59592f16939c4
https://doi.org/10.1200/jco.2022.40.16_suppl.1537
https://doi.org/10.1200/jco.2022.40.16_suppl.1537
Autor:
Veronique Debien, Virginie ADAM, Rafael Caparica, Debora Fumagalli, Chloé Velghe, Julie Gaye, Vanessa Correia De Nobrega, Amal Arahmani, Gabriele Zoppoli, Martine J. Piccart-Gebhart
Publikováno v:
Journal of Clinical Oncology. 40:TPS621-TPS621
TPS621 Background: Human Epidermal growth factor Receptor-2 positive (HER2+) breast cancer (BC) heterogeneity can be captured at the mRNA level by the PAM50 classification. The HER2 “Enriched” (HER2-E) intrinsic subtype is encountered more often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8086e5418888a60c713c10fa937dcdb
https://doi.org/10.1200/jco.2022.40.16_suppl.tps621
https://doi.org/10.1200/jco.2022.40.16_suppl.tps621
Autor:
Matteo Lambertini, Marcello Ceppi, Richard Anderson, David A. Cameron, Sarra El-Abed, Yingbo Wang, Christophe Lecocq, Paolo Nuciforo, Rebecca Rolyance, Lajos Pusztai, Joohyuk Sohn, Luca Arecco, Lucia Del Mastro, Ann H. Partridge, Cristina Saura, Michael Untch, Martine J. Piccart-Gebhart, Serena Di Cosimo, Evandro de Azambuja, Isabelle Demeestere
Publikováno v:
Journal of Clinical Oncology. 40:12084-12084
12084 Background: The potential gonadotoxicity of anti-HER2 agents remains largely unknown and limited conflicting evidence exists for taxanes. Anti-Mullerian hormone (AMH) is an established biomarker of ovarian reserve; its measurement during system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd80cb00f7acdab99c534a9636dfff6e
https://doi.org/10.1200/jco.2022.40.16_suppl.12084
https://doi.org/10.1200/jco.2022.40.16_suppl.12084
Publikováno v:
Revue de Chirurgie Orthopédique et Traumatologique. 104:200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9878f508f9ca703248c0e8ff9a09d7f9
https://doi.org/10.1016/j.rcot.2017.10.009
https://doi.org/10.1016/j.rcot.2017.10.009
Autor:
Hans-Joachim Lück, G. W. Sledge, John R. Mackey, Laura Biganzoli, Martine J. Piccart-Gebhart, Patrick Therasse, Gul Basaran, S Chan, James Carmichael, M. Bontenbal, Robert Paridaens, Jacek Jassem, Jean-Marc Nabholtz, Marc Buyse, J. Bonneterre, Tomasz Burzykowski
Publikováno v:
Journal of Clinical Oncology, 26(12), 1987-1992. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 26(12), 1987-1992. American Society of Clinical Oncology
Journal of Clinical Oncology, 26(12), 1987-1992. American Society of Clinical Oncology
Purpose Overall survival (OS) can be observed only after prolonged follow-up, and any potential effect of first-line therapies on OS may be confounded by the effects of subsequent therapy. We investigated whether tumor response, disease control, prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea0ef331e173756a44d779ac6f6680d
https://doi.org/10.1200/jco.2007.10.8407
https://doi.org/10.1200/jco.2007.10.8407
Autor:
A.S. Coates, E.P. Winer, A. Goldhirsch, R.D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thürlimann, H.-J. Senn, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Harold Burstein, Fatima Cardoso, Monica Castiglione-Gertsch, Alan S. Coates, Marco Colleoni, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John F. Forbes, Viviana Galimberti, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela Goodwin, Nadia Harbeck, Daniel F. Hayes, Jens Huober, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine J. Piccart-Gebhart, Kathleen I. Pritchard, Emiel J.T. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Zhi-Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gunter von Minckwitz, Toru Watanabe, Timothy Whelan, Eric P. Winer, Binghe Xu
Publikováno v:
Annals of oncology, 26 (8
Annals of Oncology
Annals of Oncology
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast cancer. Further experience has supported the adequacy of tumor margins defined as 'no ink on in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563d6d619f34a8e86feebcec50f65a28
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/218244
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/218244